Ability of a Specific ERK Signal-Pathway Inhibitor to Reverse P-Glycoprotein-Mediated Vincristine Resistance in Colon Cancer Cell Lines

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.